Over the past 12 months, 1 insider at TherapeuticsMD, Inc. filed 1 open-market SEC Form 4 transaction on TXMD: 1 purchase worth $14K and 0 sales worth $0. Insiders have been net buyers over this period. The most recent filing was on Dec 23, 25.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 23, 25 | Tommy G ThompsonDirector | BUY | 8.4K | $1.67 | $14K |
| Apr 14, 25 | Tommy G ThompsonDirector | BUY | 325 | $1.00 | $325 |
| Apr 14, 25 | Marlan D WalkerChief Executive Officer | BUY | 490 | $1.00 | $490 |
| Apr 10, 25 | Marlan D WalkerChief Executive Officer | BUY | 1.2K | $0.86 | $1K |
| Apr 9, 25 | Marlan D WalkerChief Executive Officer | BUY | 1.1K | $0.87 | $988 |
| Aug 22, 24 | Cooper C. CollinsDirector | BUY | 4.1K | $1.73 | $7K |
| Aug 21, 24 | Cooper C. CollinsDirector | BUY | 1.2K | $1.70 | $2K |
| Dec 7, 23 | Marlan D WalkerChief Executive Officer | SELL | 4.5K | $2.24 | $10K |
| Dec 6, 23 | Marlan D WalkerChief Executive Officer | SELL | 14.5K | $2.31 | $33K |
| Apr 26, 23 | Marlan D WalkerChief Executive Officer | SELL | 692 | $3.64 | $3K |
| Apr 12, 23 | Marlan D WalkerChief Executive Officer | SELL | 1.2K | $3.65 | $4K |
| Jan 27, 23 | Michael C DoneganPrin. Fin. and Acctg. Officer | SELL | 49 | $5.09 | $249 |
| Jan 26, 23 | Michael C DoneganPrin. Fin. and Acctg. Officer | SELL | 1.6K | $5.08 | $8K |
| Jan 24, 23 | Michael C DoneganPrin. Fin. and Acctg. Officer | SELL | 7 | $5.31 | $37 |
| Jan 23, 23 | Michael C DoneganPrin. Fin. and Acctg. Officer | SELL | 1.3K | $5.34 | $7K |
| Dec 30, 22 | Rubric Capital Management LpTenPercentOwner | SELL | 29.0K | $1333.00 | $38.7M |
| Dec 9, 22 | Rubric Capital Management LpTenPercentOwner | BUY | 14.8K | $6.09 | $90K |
| Dec 9, 22 | Brian BernickCo-Chief Executive Officer | SELL | 320 | $6.31 | $2K |
| Dec 8, 22 | David Efraim RosenTenPercentOwner | BUY | 300 | $5.83 | $2K |
| Dec 7, 22 | Gail K NaughtonDirector | SELL | 3.9K | $5.26 | $21K |
| Dec 7, 22 | David Efraim RosenTenPercentOwner | BUY | 20.1K | $5.66 | $114K |
| Dec 6, 22 | Brian BernickCo-Chief Executive Officer | SELL | 935 | $4.92 | $5K |
| Dec 6, 22 | Michael C DoneganInterim CFO/CAO/VP of Finance | SELL | 910 | $4.78 | $4K |
| Dec 6, 22 | Mark A GlickmanCo-Chief Executive Officer | SELL | 440 | $4.92 | $2K |
| Dec 6, 22 | Marlan D WalkerGeneral Counsel | SELL | 1.0K | $4.95 | $5K |
| Oct 28, 22 | Rubric Capital Management LpTenPercentOwner | BUY | 7.0K | $1000.00 | $7.0M |
| Sep 30, 22 | Rubric Capital Management LpTenPercentOwner | BUY | 7.0K | $1000.00 | $7.0M |
| Jul 29, 22 | David Efraim RosenTenPercentOwner | BUY | 565.0K | $822.21 | $12.3M |
| Jul 18, 22 | David Efraim RosenTenPercentOwner | BUY | 17.7K | $6.03 | $107K |
| Jul 15, 22 | David Efraim RosenTenPercentOwner | BUY | 64.9K | $5.56 | $361K |
| Nov 30, 21 | Michael C DoneganCAO and VP of Finance | SELL | 29.8K | $0.54 | $16K |
| Nov 18, 21 | Cooper C. CollinsDirector | BUY | 1.00M | $0.58 | $580K |
| Aug 18, 21 | Cooper C. CollinsDirector | BUY | 900.0K | $0.72 | $648K |
| Aug 17, 21 | Cooper C. CollinsDirector | BUY | 100.0K | $0.77 | $77K |
| Aug 17, 21 | Karen LingDirector | BUY | 33.4K | $0.75 | $25K |
| Aug 16, 21 | Paul BisaroDirector | BUY | 50.0K | $0.79 | $40K |
| Aug 13, 21 | Tommy G ThompsonDirector | BUY | 11.0K | $0.87 | $10K |
| Aug 12, 21 | James DareccaChief Financial Officer | SELL | 93.3K | $0.87 | $81K |
Over the past 12 months, insiders at TherapeuticsMD, Inc. filed 1 open-market purchase worth $14K and 0 sales worth $0 on TXMD, which makes them net buyers over the period. The most recent Form 4 was filed on Dec 23, 25.
The largest recent open-market TXMD insider purchase in our data was $12.3M by David Efraim Rosen, TenPercentOwner, filed on Jul 29, 22.
1 different insider at TherapeuticsMD, Inc. filed open-market SEC Form 4 transactions on TXMD over the last 12 months.
InsiderTape plots every TXMD insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every TherapeuticsMD, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →